Skip to main content

Dr. Moore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moore's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Rheumatology, 2012 - 2015
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 2009 - 2012
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2009

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2015 - 2025
  • WA State Medical License
    WA State Medical License 2012 - 2017
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Rheumatology

Awards, Honors, & Recognition

  • Alpha Omega Alpha
  • Distinguished Fellow Award American College of Rheumatology, 2014
  • Outstanding Resident Award University of Colorado / Children's Hospital Colorado, 2011
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • . Detection of Anti-Ku antibodies in pediatric patients with systemic lupus erythematosus measured by a novel chemiluminescent assay
    Moore K,Seaman A, Tiongson M, Hou H, Levy D, Silverman W, Stevens AM, Fritzler MJ, Mahler M, International CORA Autoimmunity Congress, Sorrento, Italy, 2015
  • Characteristics of the Juvenile Systemic Sclerosis Cohort within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
    , Moore KF, Stevens BE, Torok KS, Li SC, et al, American College of Rheumatology Annual Meeting, Boston, MA, 2015
  • Juvenile dermatomyositis with systemic sclerosis overlap
    Moore, KF, Mexican College of Rheumatology Annual Meeting, Mexico City, MX, 2014
  • Join now to see all

Press Mentions

  • Rituximab Works in ANCA-Linked Vasculitis
    Rituximab Works in ANCA-Linked VasculitisMay 5th, 2013
  • Continued Promise for Rituximab in Vasculitides
    Continued Promise for Rituximab in VasculitidesNovember 8th, 2012

Research History

  • Site PIStudy to evaluate the efficacy and safety of anakinra in the treatment of patients with Still's disease (anaSTILLS)2016 - Present
  • Site PIFiRst line Options for Systemic JIA Treatment (FROST)2016 - Present
  • Site PIPrecision Decisions to Start Time Optimization for Biologics in Polyarticular JIA (STOP‐JIA)—Validation Phase2016 - Present
  • Site PIChildhood Arthritis and Rheumatology Research Alliance registry2016 - Present

Professional Memberships

Hospital Affiliations